Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study

By Poyurovsky Michael   Fuchs Camil   Pashinian Artashez   Levi Aya   Faragian Sarit   Maayan Rachel   Gil-Ad Irit  

Psychopharmacology, Vol. 192, Iss. 3, 2007-06 ,pp. : 441-448

Springer Publishing Company

Access to resources Recommend Favorite

A Randomized, Double-blind, Placebo-controlled Trial of a New Weight-reducing Agent of Natural Origin

By Thom E  

The Journal of International Medical Research, Vol. 28, Iss. 5, 2000-09 ,pp. : 229-233

Field House Publishing

Access to resources Recommend Favorite

Flutamide in unresectable pancreatic adenocarcinoma: A randomized, double-blind, placebo-controlled trial

By Negi Sanjay   Agarwal Anil   Chaudhary Adarsh  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 189-194

Springer Publishing Company

Access to resources Recommend Favorite

A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression

By Hantsoo Liisa   Ward-O’Brien Deborah   Czarkowski Kathryn   Gueorguieva Ralitza   Price Lawrence   Epperson C.  

Psychopharmacology, Vol. 231, Iss. 5, 2014-03 ,pp. : 939-948

Springer Publishing Company

Access to resources Recommend Favorite

Nicergoline in the long term treatment of mild or moderate senile dementia. A multicenter double-blind, randomized, placebo-controlled trial

By Nicergoline Dementia Long Term Study Italian Group   Battaglia A.   Annoni K.   Pamparana F.   De Paolis C.   Bonura M.L.   Stekke W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 383-383

Elsevier

Access to resources Recommend Favorite